Baxter International BAX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Healthcare Systems & Technologies | $3.07B+4.1% | $2.95B-2.1% | $3.01B— | —— | |
| Medical Products & Therapies | $5.3B+1.8% | $5.21B+3.9% | $5.01B— | —— | |
| Pharmaceuticals | $2.49B+3.4% | $2.41B+7.2% | $2.25B— | —— | |
| Net Sales by Product | |||||
| Advanced Surgery | $1.2B+8.5% | $1.1B+5.0% | $1.05B+5.3% | $998M+2.1% | |
| Care & Connectivity Solutions | $1.91B+5.3% | $1.81B+0.7% | $1.8B— | —— | |
| Drug Compounding | $1.14B+9.9% | $1.04B+15.1% | $902M— | —— | |
| Front Line Care | $1.16B+2.0% | $1.14B-6.2% | $1.21B+5.6% | $1.15B+1,540% | |
| Infusion Therapies & Technologies | $4.1B0.0% | $4.1B+3.6% | $3.96B— | —— | |
| Injectables & Anesthesia | $1.35B-1.5% | $1.37B+1.9% | $1.35B— | —— | |
| Net Sales by Geography | |||||
| International | $5.12B+7.0% | $4.79B-22.3% | $6.16B— | —— | |
| United States | $6.12B+4.6% | $5.85B-8.4% | $6.39B+9.8% | $5.81B+17.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Baxter International break its business down?
- Baxter International (BAX) reports net sales by business across 3 parts — Healthcare Systems & Technologies, Medical Products & Therapies and Pharmaceuticals. Each is extracted from the segment footnotes and tracked over time.
- Where does Baxter International's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Baxter International's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
